Medical Treatments for Prostate CancerThere are many different medical treatments for prostate cancer that involve the clinical care of a healthcare professional. These treatments include expectant therapy, surgery, radiation therapy, hormone therapy, and chemotherapy. Expectant therapy is to carefully observe and monitor the prostate cancer. Because prostate cancer cells often spread very slowly, many older men who have the disease may not need more extensive treatment. However, expectant therapy usually includes routine physician examinations, including digital rectal exams and PSA tests. The different types of surgery for prostate cancer are radical prostatectomy - an open-surgery procedure in which the entire prostate gland and surrounding tissue are removed. Transurethral resection of the prostate (TURP) - surgery to remove part of the prostate gland that surrounds the urethra. Cryosurgery - this procedure involves killing the cancer cells by freezing them with a small metal tool placed in the tumor. Side effects of prostate cancer surgery include incontinence and impotence. Incontinence is the inability to control urine and may result in dribbling of urine, especially immediately after surgery. Normal control usually returns within weeks or months after surgery. Impotence is the inability to achieve an erection. For a month, or so, after surgery, most men are not able to get an erection. Eventually, approximately 40 to 60 percent of men will be able to get an erection sufficient for sexual intercourse, but without ejaculation of semen, since removal of the prostate gland prevents that process.Radiation therapy uses high energy rays to kill or shrink cancer cells, and to decrease their ability to divide. Radiation is often used to treat prostate cancer that is still confined to the prostate gland, or has spread only to nearby tissue. If the disease is advanced, radiation may be used to reduce the size of the tumor and to provide relief from symptoms. Possible side effects of radiation for prostate cancer may include diarrhea, with or without blood in the stool, and colitis, problems associated with urination, a degree of impotence (inability to get an erection), which may occur within two years of radiation therapy. The goal of hormone therapy is to lower the level of male hormones in the body, particularly testosterone. Hormone therapy does not cure the cancer, and is often used to treat persons whose cancer has spread or recurred after treatment. Produced mainly in the testicles, testosterone causes prostate cancer cells to grow. Thus, reduced testosterone levels can make the prostate cancer shrink and become less active. Most studies show that hormone therapy works better if it is started early. Chemotherapy is the use of powerful, anti-cancer medications to kill cancer cells.. Hospitalization may be needed to monitor treatment and chemotherapy's side effects. Common side effects of chemotherapy include: nausea and vomiting, hair loss, anemia, reduced ability of blood to clot, mouth sores, increased likelihood of developing infections, fatigue. Most side effects disappear once treatment is stopped. |
| hormone refractory prostate cancer treatment |
|
IngentaConnect Treatment Options in Hormone-Refractory Prostate Treatment Options in Hormone-Refractory Prostate Cancer: Current and Future Approaches. Authors: Harris K.A.1; Reese D.M.1. Source: Drugs, Volume 61, Achieving Treatment Goals for Hormone-Refractory Prostate Cancer Achieving Treatment Goals for Hormone-Refractory Prostate Cancer with Chemotherapy. William Berrya, Mario Eisenbergerb. a Cancer Centers of North Carolina, Metastatic And Hormone Refractory Prostate cancer Metastatic And Hormone Refractory Prostate cancer (HRPC). Introduction. Prostate cancer is the most Treatment options for metastatic prostate cancer 59 Chemotherapy for hormone-refractory prostate cancer Chemotherapy offers a treatment option for men with hormone-refractory prostate cancer (HRPC), but the decision to treat should be carefully considered by Stakeholder Insight: Metastatic And Hormone Refractory Prostate cancer Stakeholder Insight: Metastatic And Hormone Refractory Prostate cancer becoming the treatment of choice for hormone refractory prostate cancer (HRPC). ijcp_1551 2064..2070 hormone-refractory prostate cancer (HRPC) to provide recommendations for the. treatment of this important patient group. Methods: The information for this Blackwell Synergy - BJU Int, OnlineEarly Articles (Full Text) Treating asymptomatic patients with hormone-refractory prostate cancer: . Advanced prostate cancer treatment guidelines: a United States perspective. Locally Advanced and Recurrent Disease : Hormone-Refractory Quality of life (QOL) of patients (pts) with metastatic hormone refractory prostate cancer (mHRPC) following treatment with docetaxel or mitoxantrone in the National Prostate Cancer Coalition: Treatment Combination Highly Treatment Combination Highly Effective in Hormone-Refractory Prostate Cancer. CancerConsultants.com | 06.06.2006. ATLANTA, Ga. -- The treatment combination Us TOO International Prostate Cancer Education & Support Network Researchers are diligently trying to find new types of treatment for hormone-refractory prostate cancer (cancer that no longer responds to hormonal therapy) Treatment of Hormone Refractory Prostate Cancer with Quadramet and Treatment of advanced, hormone refractory prostate cancer with the chemotherapy drug Taxotere and Quadramet reduces prostate specific antigen (PSA) levels. Prostate cancer (hormone-refractory) - docetaxel Docetaxel is recommended as a possible treatment for men with hormone-refractory metastatic prostate cancer. It should be given only if the man is well Hormone-Refractory Prostate Cancer with Bone Metastases - Prostate Newer Concepts in the Treatment of Hormone-Refractory Prostate Cancer with Bone Metastases: Combinations of Bone-Seeking Radiopharmaceuticals and Management of hormone-refractory prostate cancer, from the Hormone-Refractory Prostate Cancer: An Overview. Last Revised March 18, 1996 Note: Treatment may have evolved since this was written. For education only. BA - Chemotherapy For Hormone Refractory Prostate Cancer (HRPC) BA - Chemotherapy For Hormone Refractory Prostate Cancer (HRPC) . A Paradigm Shift in the Treatment Management of Prostate Cancer New Prospects in the Treatment of Hormone-Refractory Prostate Cancer We are pleased to offer you New Prospects in the Treatment of Hormone-Refractory Prostate Cancer, a CME newsletter that offers medical oncologists the Hormone Refractory Prostate Cancer - hrpca.org For those men facing hormone refractory prostate cancer. our teams with doctors who respect the fact that we are in charge of our own treatment program. Prostate Cancer Treatment - National Cancer Institute Surprising activity of flutamide withdrawal, when combined with aminoglutethimide, in treatment of "hormone-refractory" prostate cancer. |
| hormone refractory prostate cancer treatment |
|
mri prostate cancer hormone resistant prostate cancer homemade massager prostate internal prostate massage |